GSK in­fus­es $120M in­to next-gen man­u­fac­tur­ing fa­cil­i­ties at Up­per Meri­on, PA

In the lat­est move to bring its man­u­fac­tur­ing ca­pa­bil­i­ties up to speed with the lat­est tech­no­log­i­cal ad­vances, Glax­o­SmithK­line has ded­i­cat­ed $120 mil­lion to an ex­pan­sion at its long­time site in Up­per Meri­on, Penn­syl­va­nia.

The up­grade is meant to ren­der the fa­cil­i­ty more flex­i­ble than tra­di­tion­al man­u­fac­tur­ing op­er­a­tions, GSK said. You can ex­pect to see sin­gle-use and dis­pos­able com­po­nents, al­low­ing for a quick tran­si­tion be­tween the pro­duc­tion of one med­i­cine to an­oth­er; stream­lined qual­i­ty and com­mer­cial test­ing process­es; as well as a new an­a­lyt­i­cal lab.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER